Clinical Trial Update: Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating recombinant human endostatin combined with NP chemotherapy as neoadjuvant treatment for stage IIIA non-small cell lung cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)
• Nedaplatin (nedaplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Non Small Cell Lung Cancer | Phase 4 | Status: COMPLETED